Effects of ARID1A loss on transcriptional regulation in hepatocellular carcinoma cell line PLC/PRF/5

Abstract

Abstract: Objective To explore the transcriptional alterations regulated by ARID1A in hepatocellular carcinoma cell line PLC/PRF/5. Methods CRISPR/Cas9 technology was utilized to generate ARID1A knockout cells. RNA-seq was then performed in both ARID1A intact and ARID1A null PLC/PRF/5 cells to generate gene expression profiles. Differentially expressed genes were identified using DESeq2. Functional enrichment analysis of differentially expressed genes was performed using metascape database. Results Successful generation of the ARID1A knockout PLC/PRF/5 cells was confirmed by Western blot and Sanger sequencing. A total of 978 differentially expressed genes were identified by RNA-seq, among which the expression of 480 genes was up-regulated and that of 498 genes was down-regulated. These differentially expressed genes were mainly enriched in several biological processes including cell adhesion, regulation of hormone levels, hormone metabolism and regulation of MAP kinase activity. Conclusions The results indicate that ARID1A loss induces alterations in transcription in PLC/PRF/5, which may provide novo clues for elucidating the underlying mechanism of ARID1A in tumorigenesis.

Key words: ARID1A, CRISPR, RNA-seq, hepatocellular carcinoma cell line PLC/PRF/5

CLC Number:

WANG Ding-ding, LIANG Jun-bo, WANG Xiao-yue. Effects of ARID1A loss on transcriptional regulation in hepatocellular carcinoma cell line PLC/PRF/5[J]. Basic & Clinical Medicine, 2020, 40(4): 501-505.

References

[1]Wilson BG, Roberts CW. SWI/SNF nucleosome remod-ellers and cancer[J]. Nat Rev Cancer, 2011,11:481-492.
[2]Kadoch C, Crabtree GR. Mammalian SWI/SNF chromatin remodeling complexes and cancer: mechanistic insights gained from human genomics[J]. Sci Adv, 2015,1:e1500447. doi: 10.1126/sciadv.1500447.
[3]Kadoch C, Hargreaves DC, Hodges C, et al. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy[J]. Nat Genet, 2013,45:592-601.
[4]Mathur R, Alver BH, San Roman AK, et al. ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice[J]. Nat Genet, 2017,49:296-302.
[5]Shen J, Peng Y, Wei L, et al. ARID1A deficiency impairs the DNA damage checkpoint and sensitizes cells to PARP inhibitors[J]. Cancer Discov, 2015,5:752-767.
[6]Guan B, Wang TL, Shih Ie M. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers[J]. Cancer Res, 2011,71:6718-6727.
[7]Suryo Rahmanto Y, Jung JG, Wu RC, et al. Inactivating ARID1A tumor suppressor enhances TERT transcription and maintains telomere length in cancer cells[J]. J Biol Chem, 2016,291:9690-9699.
[8]Pertea M, Kim D, Pertea GM, et al. Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown[J]. Nat Protoc, 2016,11:1650-1667.
[9]Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2[J]. Genome Biol, 2014,15:550. doi: 10.1186/s13059-014-0550-8.
[10]Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets[J]. Nat Commun, 2019,10:1523. doi:10.1038/s41467-019-09234-6.
[11]Inoue H, Furukawa T, Giannakopoulos S, et al. Largest subunits of the human SWI/SNF chromatin-remodeling complex promote transcriptional activation by steroid hormone receptors[J]. J Biol Chem, 2002,277:41674-41685.
[12]Li C, Xu ZL, Zhao Z, et al. ARID1A gene knockdown promotes neuroblastoma migration and invasion[J]. Neoplasma, 2017,64:367-376.
[13]Kim EK, Choi EJ. Compromised MAPK signaling in human diseases: an update[J]. Arch Toxicol, 2015,89:867-882.

[1]	CHEN Xinwen, CAO Jiaxuan, RAO Shuquan. Design and investigation of CRISPRi tools based on dCasMINI protein [J]. Basic & Clinical Medicine, 2024, 44(6): 821-827.
[2]	WU Qi, WANG Shaobo. Progress in CRISPR/Cas9 for CAR-T cell therapy of tumors [J]. Basic & Clinical Medicine, 2023, 43(8): 1313-1316.
[3]	ZHANG Zhiyu, CAO Jun, LIANG Junbo. Exploring the potential application of liver organoids of mouse as developmental models upon Hnf4α knockout [J]. Basic & Clinical Medicine, 2023, 43(5): 724-732.
[4]	ZHAO Yongjing, QIU Jiaxing, ZHANG Diya, GUO Hongjiang, WANG Yucheng, JU Rui, GUO Lei. Stable knockout of Mcart-1 down-regulates the proliferation and oxidative phosphorylation of RAW264.7 macrophages [J]. Basic & Clinical Medicine, 2023, 43(4): 568-575.
[5]	LI Xiaoguang, YANG Lu, LIU Xudong, JIA Xinmiao, YANG Xinzhuang, CUI Liying. Progress in gene therapy mechanism of amyotrophic lateral sclerosis [J]. Basic & Clinical Medicine, 2023, 43(4): 674-679.
[6]	ZHOU Lan, ZHANG Sheng-gui, HU Zu-liang, WANG Tian-xian, YUE Peng-peng, YU Hong-hao. Efficient editing of mouse miR let-7a based on CRISPR/Cas9 system [J]. Basic & Clinical Medicine, 2022, 42(6): 857-863.
[7]	LIU Gao-ao, PENG Xiao-zhong, SHU Peng-cheng. Effect of Dicer1 ablation on early neurodevelopment of mice [J]. Basic & Clinical Medicine, 2021, 41(6): 818-824.
[8]	SUN Meng-yao, LIU Si-qi, ZHOU Fan-qi, MA Yan-ni, YU Jia. Screening of cis-acting elements for maintaining pluripotency of human embryonic stem cells [J]. Basic & Clinical Medicine, 2021, 41(5): 636-640.
[9]	LI Meng-zhen, LIU Jun, ZOU Ding-feng, MIAO Shi-ying, WANG Lin-fang, SONG Wei, LI Kai. Application of RNA-targeted CRISPR/CasRx system in mouse spermatogonia cell line GC1-spg [J]. Basic & Clinical Medicine, 2021, 41(5): 653-660.
[10]	YUE Peng-peng, LI Cheng-qin, NONG Yue-juan, CHEN Ling, FU Can, YU Hong-hao. Establishing a CRISPR-Cas9 system targeting at mouse Krt14 that simulates pathogenic site mutations of human [J]. Basic & Clinical Medicine, 2021, 41(3): 325-332.
[11]	LIU Meng-yu, ZHOU Ya-bo, HUANG Bo, LYU Jia-di. Construction of B16 cell strain expressing CSDE1-EGFP using CRISPR-PITCH system [J]. Basic & Clinical Medicine, 2021, 41(3): 318-324.
[12]	SUN Jing-yu, YAO He, HU Gang, WEI Jie, GUO Jun, ZHANG Xin, LIN Ya-jun. HUVECs with KNDC1 knockout mediated by CRISPR/Cas9 have anti-aging ability [J]. Basic & Clinical Medicine, 2020, 40(9): 1175-1181.
[13]	HAN Ling, YANG Ke, XUE Zheng, LYU Xiang. Efficient identification of point-mutant monoclonal cells through array tagged high-throughput sequencing [J]. Basic & Clinical Medicine, 2020, 40(7): 903-911.
[14]	FENG Dong-ping, SHANG Han-qiao, YANG Hang, ZHANG Hu-jun, ZHANG Ting, YANG Meng-xi, TU Qiang, REN Jing-yi. Establishment of cetp^-/- model and liver transcriptomics study in zebrafish [J]. Basic & Clinical Medicine, 2020, 40(7): 940-947.
[15]	. Dynamic change of autophagy in mouse spermatogenesis identified by RNA-Seq [J]. Basic & Clinical Medicine, 2019, 39(5): 663-667.